14 ottobre 2021 – The Confederation has concluded an agreement with Janssen, a company of the Johnson & Johnson health group, for the delivery of 150,000 doses of vaccine. The vaccine has been delivered to Switzerland last week and distribution to the cantons starts this week. The vector-based vaccine is primarily used for people who cannot be vaccinated with an mRNA vaccine for medical reasons. However, it is also available to others who wish to be vaccinated.

For more information, see here.